Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
Public ClinicalTrials.gov record NCT01674647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Open-label, Parallel-group, Active-controlled, Multicenter Study Exploring the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY59-7939) Compared With That of Dose-adjusted Oral Vitamin K Antagonists (VKA) for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
Study identification
- NCT ID
- NCT01674647
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 1,504 participants
Conditions and interventions
Conditions
Interventions
- Rivaroxaban (Xarelto, BAY59-7939) Drug
- Vitamin K antagonist (VKA) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2012
- Primary completion
- Dec 31, 2013
- Completion
- Dec 31, 2013
- Last update posted
- Apr 29, 2015
2012 – 2014
United States locations
- U.S. sites
- 66
- U.S. states
- 23
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Scottsdale | Arizona | 85258 | — |
| Not listed | East Palo Alto | California | 94303 | — |
| Not listed | El Cajon | California | 92020 | — |
| Not listed | National City | California | 91950 | — |
| Not listed | Sacramento | California | 95819 | — |
| Not listed | Santa Rosa | California | 95494 | — |
| Not listed | Torrance | California | 90502-2004 | — |
| Not listed | New Haven | Connecticut | 06520 | — |
| Not listed | Stamford | Connecticut | 06905 | — |
| Not listed | Wilmington | Delaware | 19803 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | Daytona Beach | Florida | 32117 | — |
| Not listed | Deltona | Florida | 32725 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Fort Lauderdale | Florida | 33316 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Lakeland | Florida | 33805 | — |
| Not listed | Melbourne | Florida | 32901 | — |
| Not listed | Miami | Florida | 33135 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Saint Augustine | Florida | 32216 | — |
| Not listed | Tallahassee | Florida | 32308 | — |
| Not listed | Savannah | Georgia | 31419 | — |
| Not listed | Aurora | Illinois | 60504 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Elk Grove Village | Illinois | 60007 | — |
| Not listed | Joliet | Illinois | 60435 | — |
| Not listed | Rockford | Illinois | 61107 | — |
| Not listed | Annapolis | Maryland | 21401 | — |
| Not listed | Columbia | Maryland | 21044 | — |
| Not listed | Rockville | Maryland | 20853 | — |
| Not listed | Lincoln | Nebraska | 68516 | — |
| Not listed | North Las Vegas | Nevada | 89086 | — |
| Not listed | Bridgewater | New Jersey | 08807 | — |
| Not listed | Manalapan | New Jersey | 07716 | — |
| Not listed | Albuquerque | New Mexico | 87102 | — |
| Not listed | Buffalo | New York | 14215 | — |
| Not listed | New York | New York | 10013 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Troy | New York | 12180 | — |
| Not listed | Asheville | North Carolina | 28805 | — |
| Not listed | Cantan | Ohio | 44708 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Mansfield | Ohio | 44906 | — |
| Not listed | Toledo | Ohio | 43623 | — |
| Not listed | Beaver | Pennsylvania | 15009 | — |
| Not listed | Butler | Pennsylvania | 16001 | — |
| Not listed | Doylestown | Pennsylvania | 18901 | — |
| Not listed | Hershey | Pennsylvania | 17033 | — |
| Not listed | Philadelphia | Pennsylvania | 19102 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| Not listed | Johnson City | Tennessee | 37604 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Austin | Texas | 78745 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Fort Sam Houston | Texas | 78234-6200 | — |
| Not listed | Tyler | Texas | 75701 | — |
| Not listed | Layton | Utah | 84041 | — |
| Not listed | Bellingham | Washington | 98225 | — |
| Not listed | Burien | Washington | 98166 | — |
| Not listed | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 112 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01674647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01674647 live on ClinicalTrials.gov.